We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTK
10451
DELISTED
CooTek (Cayman) Inc. American Depositary Shares, each representing 650 Class A Ordinary Shares
CTK
$47K ﹤0.01%
+1,303
New +$75.6K
EPM icon
10452
PUT
Evolution Petroleum
EPM
$129M
$46K ﹤0.01%
16,100
-10,400
-39% -$26.3K
KXIN icon
10453
PUT
Kaixin Holdings
KXIN
$8.78M
0
PHX
10454
CALL
DELISTED
PHX Minerals
PHX
$46K ﹤0.01%
+19,900
New +$36.1K
TRX icon
10455
CALL
TRX Gold Corp
TRX
$258M
$46K ﹤0.01%
69,700
-16,700
-19% -$10.9K
XIN
10456
DELISTED
Xinyuan Real Estate
XIN
$46K ﹤0.01%
2,069
-405
-16% -$8.77K
XPRO icon
10457
CALL
Expro Ltd
XPRO
$1.79B
$46K ﹤0.01%
+2,783
New +$36.4K
DMS.WS
10458
DELISTED
Digital Media Solutions, Inc. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
DMS.WS
$46K ﹤0.01%
29,345
-1,229
-4% -$1.19K
ACOR
10459
CALL
DELISTED
Acorda Therapeutics
ACOR
$46K ﹤0.01%
551
+203
+58% +$18.7K
GSV
10460
DELISTED
Gold Standard Ventures Corp.
GSV
$46K ﹤0.01%
63,126
-174,968
-73% -$126K
NBRV
10461
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$46K ﹤0.01%
757
+638
+536% +$69.1K
CO
10462
DELISTED
Global Cord Blood Corporation
CO
$46K ﹤0.01%
12,302
-26
-0.2% -$100
LJPC
10463
DELISTED
La Jolla Pharmaceutical Company
LJPC
$46K ﹤0.01%
11,801
-10,106
-46% -$43.2K
ANIX icon
10464
Anixa Biosciences
ANIX
$116M
$45K ﹤0.01%
+14,498
New +$36.4K
CEPU
10465
Central Puerto
CEPU
$2.24B
$45K ﹤0.01%
+16,768
New +$41.3K
GIGM icon
10466
GigaMedia
GIGM
$15.4M
$45K ﹤0.01%
+14,031
New +$40.7K
RAIL icon
10467
FreightCar America
RAIL
$270M
$45K ﹤0.01%
18,849
+6,810
+57% +$14.9K
TLSA icon
10468
CALL
Tiziana Life Sciences
TLSA
$123M
$45K ﹤0.01%
+22,200
New +$70.2K
VTNR
10469
CALL
DELISTED
Vertex Energy, Inc
VTNR
$45K ﹤0.01%
+63,800
New +$36.3K
GLOP
10470
PUT
DELISTED
GASLOG PARTNERS LP
GLOP
$45K ﹤0.01%
16,700
-12,400
-43% -$37.8K
TMDI
10471
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$45K ﹤0.01%
26,409
-904
-3% -$898
HIL
10472
DELISTED
Hill International, Inc. Common Stock
HIL
$45K ﹤0.01%
23,447
+8,384
+56% +$13.8K
NBRV
10473
CALL
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$45K ﹤0.01%
+748
New +$81K
NAVB
10474
CALL
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$45K ﹤0.01%
+20,700
New +$48.8K
EVK
10475
DELISTED
Ever-Glory International Group, Inc.
EVK
$45K ﹤0.01%
+14,758
New +$34K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.